mani
virus
harbor
viral
protein
specif
function
gear
toward
prevent
ifni
product
andor
signal
highlight
evolutionari
select
pressur
exert
ifni
viral
replic
devasthanam
absenc
ifni
signal
acut
viru
infect
vivo
increas
viru
replic
dissemin
lethal
multipl
viral
infect
anim
model
global
delet
result
enhanc
mortal
vesicular
stomat
viru
vsv
vaccinia
viru
vv
west
nile
viru
wnv
lymphocyt
choriomening
viru
lcmv
infect
muller
et
al
moreov
infect
ko
mice
acut
lcmv
armstrong
arm
nakayama
et
al
zhou
cerni
fitzgerald
kurtjon
finberg
treatment
arminfect
mice
neutral
antibodi
elev
viral
load
promot
viru
persist
teijaro
et
al
wilson
et
al
dendrit
cellspecif
delet
result
elev
viru
replic
system
persist
strain
murin
noroviru
mnov
despit
increas
cellmedi
humor
adapt
immun
respons
nice
et
al
ifni
signal
shown
essenti
control
wnv
infect
restrict
viral
pathogenesi
sheehan
lazear
diamond
schreiber
mice
defici
signal
display
increas
suscept
wnv
infect
pinto
et
al
samuel
diamond
infect
coronaviru
mous
hepat
viru
magnitud
ifni
ii
respons
directli
correl
viral
load
raaben
koerkamp
rottier
de
haan
moreov
ifni
produc
plasmacytoid
dendrit
cell
pdc
essenti
control
viru
replic
prevent
mortal
follow
infect
mice
cervantesbarragan
et
al
experiment
infect
mice
nonhuman
primat
lassa
hemorrhag
fever
viru
delay
reduc
induct
ifni
downstream
gene
signatur
correl
high
viral
load
fatal
outcom
baiz
et
al
yun
et
al
delet
ifni
relat
signal
pathway
respiratori
viru
infect
anim
model
result
divers
effect
depend
viru
strain
genet
background
durbin
et
al
price
gaszewskamastarlarz
moskophidi
context
respiratori
viral
infect
genet
delet
reduc
viru
control
enhanc
patholog
mortal
sarscov
influenza
viru
infect
durbin
et
al
frieman
et
al
interestingli
anim
highli
suscept
influenza
viru
infect
display
elev
viral
titer
increas
patholog
compar
mice
studi
mous
model
influenza
viru
reveal
conflict
evid
role
control
influenza
viru
replic
morbid
mortal
infect
mice
strain
influenza
viru
result
alter
recruit
hi
vs
int
monocyt
lung
translat
increas
product
neutrophil
chemoattract
kc
elev
number
neutrophil
lung
increas
morbid
mortal
seo
et
al
therefor
modul
type
interferon
signal
product
need
balanc
enough
control
viru
infect
promot
excess
inflamm
discrep
influenza
pathogen
mice
later
clarifi
anim
lack
unabl
control
influenza
viru
replic
support
human
null
mutat
human
interferon
regulatori
gene
result
reduc
ifni
iii
product
myeloid
dc
pdc
lifethreaten
season
influenza
viru
infect
ciancanelli
et
al
exposur
bone
marrow
cell
ifni
prior
recruit
lung
endow
cell
antivir
program
protect
viru
infect
entri
infect
lung
hermesh
moltedo
moran
lopez
delet
gene
mice
function
gene
increas
viru
replic
reduc
ld
koerner
koch
kalink
weiss
staeh
infect
mice
low
dose
mous
adapt
influenza
virus
result
mortal
elev
viral
load
exacerb
lung
patholog
reduc
number
cell
compar
control
arimori
et
al
moreov
exogen
administr
anim
follow
influenza
viru
infect
partial
restor
surviv
amelior
lung
patholog
thu
ifni
protect
influenza
viru
infect
either
suppress
viru
spread
prompt
induct
immunesuppress
cytokin
reign
excess
inflamm
addit
directli
inhibit
viru
propag
ifni
also
potent
immun
stimulatori
function
support
resolut
viru
infect
ifni
promot
upregul
mhci
express
multipl
cell
lineag
lindahl
gresser
leari
tovey
requir
optim
cell
stimul
differenti
expans
kill
virusinfect
cell
autocrin
signal
ifni
dendrit
cell
promot
activ
cell
stimulatori
capac
montoya
et
al
ifni
signal
viru
infect
promot
convers
pdc
myeloid
deriv
dc
impair
hematopoiet
differenti
bone
marrow
progenitor
dc
sevilla
mcgavern
teng
kunz
oldston
zuniga
mcgavern
prunedapaz
teng
oldston
follow
exposur
ifni
metallophil
macrophag
induc
express
protein
prevent
phosphoryl
inhibit
ifni
signal
cell
turn
repress
ifni
signal
allow
restrict
viru
replic
macrophag
promot
product
viral
antigen
recogn
b
cell
final
result
facilit
antivir
antibodi
gener
enhanc
viru
control
honk
et
al
ifni
also
exert
potent
costimulatori
effect
directli
cell
enhanc
cell
prolifer
upon
signal
curtsing
valenzuela
agarw
lin
mescher
kolumam
thoma
thompson
sprent
muralikrishna
time
cell
exposur
ifni
significantli
influenc
differenti
magnitud
respons
welsh
bahl
marshal
urban
exposur
cell
apc
ifni
prior
antigen
stimul
promot
mainten
phenotyp
reduc
prolifer
despit
product
effector
cytokin
direct
ifni
signal
memori
cell
promot
rapid
apoptosi
inhibit
prolifer
promot
earli
effector
differenti
memori
cell
upon
exposur
blockad
ifni
signal
wnv
infect
signific
effect
cell
expans
cytokin
product
differenti
administ
matur
phase
cell
respons
howev
effect
given
prior
infect
pinto
et
al
moreov
low
dose
prime
vv
ankara
strain
littl
effect
effector
memori
cell
recal
mice
volz
langenmay
jani
kalink
sutter
addit
cell
ifni
signal
known
import
nk
cell
function
ifni
signal
promot
nk
cell
cytolyt
capac
surviv
acut
viral
infect
hwang
et
al
martinez
huang
yang
nguyen
et
al
recent
report
protect
antivir
cell
nk
cell
lytic
effect
crous
et
al
xu
et
al
reconstitut
mice
nk
cell
restor
earli
control
vv
infect
vivo
martinez
et
al
suggest
nk
cell
intrins
signal
import
earli
control
vv
replic
moreov
direct
ifni
signal
nk
cell
requir
induc
nk
cell
product
acut
lcmv
infect
earli
signal
requir
promot
initi
viru
control
peritoneum
mack
kallal
demer
biron
suggest
ifni
signal
directli
nk
cell
promot
viru
control
acut
lcmv
infect
ifni
signal
viral
infect
also
signal
regulatori
cell
subsequ
alter
suppress
function
recent
demonstr
signal
treg
limit
suppress
function
acut
lcmv
infect
thu
promot
viru
control
srivastava
koch
pepper
campbel
delet
cell
blunt
virusspecif
cell
respons
elev
viru
load
thu
ifni
signal
suppress
cell
popul
temporarili
suspend
suppress
function
allow
optim
antivir
cell
respons
ongo
viral
infect
similar
effect
cell
ifni
signal
posit
le
bon
et
al
neg
effect
antivir
b
cell
respons
surviv
matur
immatur
b
cell
inhibit
ifni
signal
lin
dong
cooper
contrast
immatur
b
cell
ifni
signal
promot
b
cell
activ
antibodi
product
isotyp
switch
follow
influenza
vsv
wnv
infect
coro
chang
baumgarth
fink
et
al
purtha
chachu
virgin
diamond
rau
dieter
luo
priest
baumgarth
howev
also
report
influenza
virusspecif
antibodi
level
elev
later
time
point
follow
influenza
viru
challeng
mice
compar
control
price
et
al
acut
lcmv
infect
blockad
ifni
signal
wildtyp
mice
enhanc
follicular
helper
cell
fh
germin
center
b
cell
differenti
antilcmv
antibodi
respons
ray
et
al
elev
antibodi
respons
acut
viral
infect
follow
blockad
suggest
certain
circumst
ifni
signal
restrain
optim
antivir
antibodi
respons
correl
aggress
immun
respons
sever
diseas
follow
influenza
viru
infect
human
anim
model
discuss
previous
la
gruta
kedzierska
stamba
doherti
aggress
innat
respons
elev
recruit
inflammatori
leukocyt
lung
like
contribut
morbid
influenza
infect
ahm
oldston
pales
kobasa
et
al
fact
lung
injuri
infect
macaqu
influenza
viru
strain
directli
correl
earli
dysregul
inflammatori
gene
express
includ
elev
ifni
signatur
cilloniz
et
al
kobasa
et
al
recent
clinic
studi
avian
human
document
signific
associ
excess
earli
cytokin
respons
immun
cell
recruit
predict
poor
outcom
de
jong
et
al
aberr
cytokinechemokin
respons
observ
patient
sever
diseas
recent
pandem
arankal
et
al
type
interferon
signal
well
known
inhibit
influenza
viru
replic
spread
garciasastr
biron
product
protein
one
viral
protein
act
inhibit
type
interferon
product
signal
hale
randal
ortin
jackson
suggest
ifni
signal
exert
substanti
select
pressur
viru
fit
delet
mutat
gene
result
signific
increas
level
type
interferon
infect
cell
significantli
lower
viru
titer
vitro
vivo
garciasastr
egorov
et
al
jiao
et
al
koch
garciasastr
martinezsobrido
despit
strong
evid
demonstr
extens
antivir
properti
ifni
sever
studi
also
suggest
pathogen
role
influenza
viru
infect
product
sever
proinflammatori
cytokin
chemokin
known
amplifi
ifni
receptor
signal
addit
protect
effect
ifni
signal
pathogen
role
ifni
report
influenza
viru
infect
fig
appear
lavag
fluid
directli
coincid
symptom
onset
human
experiment
influenza
viru
infect
hayden
et
al
suggest
ifni
signal
patholog
respons
human
tempor
coincid
recent
paradox
report
delet
deplet
pdc
mice
inhibit
pulmonari
patholog
improv
surviv
follow
lethal
influenza
viru
challeng
davidson
crotta
mccabe
wack
reduc
immun
patholog
enhanc
surviv
mice
defici
ifni
signal
transpir
without
signific
increas
viral
load
impedi
eventu
viral
clearanc
fig
contrast
delet
ifni
signal
treatment
influenza
virusinfect
mice
result
enhanc
morbid
mortal
thu
ifni
promot
patholog
consequ
acut
influenza
viru
infect
past
year
identifi
therapeut
administr
sphingosin
phosphat
analog
earli
influenza
viru
infect
mice
result
reduc
morbid
mortal
lipid
metabolit
convert
ceramid
precursor
sphingosin
fig
ifni
signal
enhanc
cytokinechemokin
amplif
innat
immun
cell
recruit
immun
patholog
respiratori
viral
infect
viral
infect
lung
influenza
sarscov
promot
induct
delay
ifni
product
enhanc
cytokinechemokin
product
recruit
nk
cell
neutrophil
inflammatori
macrophagemonocyt
contribut
lung
immunemedi
patholog
b
blockad
genet
delet
blunt
cytokinechemokin
amplif
inhibit
recruit
nk
cell
neutrophil
inflammatori
macrophagesmonocyt
result
reduc
immunopatholog
improv
surviv
treatment
mice
agonist
earli
influenza
viru
infect
suppress
ifni
amplif
plasmacytoid
dendrit
cell
lower
ifni
level
end
result
blunt
cytokinechemokin
amplif
inhibit
nk
cell
neutrophil
inflammatori
macrophagemonocyt
recruit
lung
reduc
immunopatholog
improv
surviv
subsequ
phosphoryl
sphingosin
kinas
produc
bioactiv
vivo
act
gprotein
coupl
receptor
gpcr
chalfant
spiegel
level
bioactiv
regul
action
phosphatas
lyas
dephosphoryl
degrad
respect
highest
level
found
blood
lymph
significantli
lower
level
maintain
peripher
tissu
cyster
bind
signal
five
gpcr
denot
coupl
variou
gprotein
signal
effector
express
receptor
heterogen
found
hematopoiet
nonhematopoiet
lineag
im
function
coupl
multipl
heterotrimer
gprotein
promot
divers
cellular
function
associ
receptor
signal
signal
five
receptor
known
modul
multipl
cellular
process
includ
cell
adhes
migrat
surviv
prolifer
endocytosi
barrier
function
cytokin
product
rivera
proia
olivera
recent
identifi
novel
regulatori
function
signal
blunt
earli
cytokin
amplif
innat
immun
cell
recruit
follow
influenza
viru
infect
fig
earli
administr
promiscu
agonist
aalr
agonist
significantli
blunt
product
multipl
proinflammatori
cytokin
chemokin
follow
infect
either
wsn
human
pandem
influenza
viru
walsh
et
al
aalrand
reduct
earli
innat
immun
cell
recruit
cytokinechemokin
product
correl
directli
reduc
lung
patholog
improv
surviv
influenza
viru
infect
agonist
clearli
inhibit
innat
immun
respons
signific
inhibit
activ
cell
recruit
lung
variou
time
post
infect
occur
mous
adapt
marsolai
et
al
human
pathogen
strain
influenza
viru
find
extend
use
genet
chemic
tool
probe
function
receptor
gfp
knockin
transgen
mice
receptor
agonist
antagonist
reveal
pulmonari
endotheli
cell
modul
innat
immun
cell
recruit
cytokinechemokin
respons
earli
follow
influenza
viru
infect
importantli
agonist
treatment
blunt
cytokinechemokin
product
innat
immun
cell
recruit
lung
independ
endosom
cytosol
innat
sens
pathway
teijaro
walsh
rice
rosen
oldston
signal
suppress
cytokin
amplif
independ
multipl
innat
signal
adaptor
pathway
requir
adaptor
cytokin
amplif
follow
influenza
viru
challeng
immun
cell
infiltr
cytokin
product
found
distinct
event
orchestr
signal
suppress
earli
innat
immun
respons
signal
also
reduc
mortal
infect
human
pathogen
strain
swine
influenza
viru
ferret
model
demonstr
blunt
influenza
viru
pathogenesi
mice
could
extend
model
close
resembl
human
diseas
link
amplif
follow
influenza
viru
infect
strike
fact
absenc
abolish
cytokin
amplif
capac
agonist
blunt
cytokinechemokin
respons
teijaro
et
al
understand
signal
regul
cytokin
amplif
assess
pulmonari
cell
subset
produc
cytokineschemokin
follow
influenza
viru
challeng
express
quickli
observ
purifi
pdc
moreov
agonist
suppress
ifni
inductionamplif
mous
human
pdc
follow
influenza
viru
simul
teijaro
et
al
mechanist
studi
reveal
agonistmedi
suppress
independ
gio
signal
requir
signal
cterminu
biochem
agonist
acceler
turnov
promot
traffick
lysosom
degrad
abrog
phosphoryl
blunt
ifni
autoamplif
loop
fact
ifni
productionsign
modul
expressionact
indirectli
upregul
promot
intern
cell
signific
shiow
suggest
ifni
signal
close
link
capabl
counter
regul
one
anoth
addit
studi
also
report
ifni
modul
pdc
via
dillmann
et
al
suggest
phenomenon
could
promiscu
origin
thought
similar
influenza
viru
infect
aberr
innat
cytokinechemokin
respons
immun
cell
recruit
lung
correl
diseas
sever
human
patient
huang
et
al
ifni
signal
murin
sarscov
infect
appear
dispens
viru
control
also
potenti
immun
patholog
howev
role
ifni
signal
play
patholog
recent
systemat
address
delet
mice
mirror
enhanc
viral
load
patholog
consequ
observ
mice
sarscov
infect
suggest
pathway
necessari
control
sarscov
frieman
et
al
studi
provoc
suggest
ifni
signal
dispens
control
sarscov
replic
vivo
recent
import
studi
publish
author
highlight
import
ifni
signal
respiratori
viru
patholog
report
delay
ifni
induct
signal
sarscov
infect
mice
promot
develop
infiltr
inflammatori
monocytemacrophag
lung
result
exacerb
lung
patholog
lethal
pneumonia
channappanavar
et
al
attenu
ifni
signal
either
genet
delet
antibodi
neutral
prevent
inflammatori
monocytemacrophag
infiltr
lung
abrog
lung
immun
patholog
result
mild
clinic
diseas
importantli
genet
delet
blockad
ifni
signal
result
control
viral
load
similar
control
anim
reinforc
ifni
signal
dispens
control
sarscov
infect
vivo
one
possibl
absenc
ifni
signal
induct
ifniii
antivir
program
may
effect
limit
viral
replic
result
found
studi
strikingli
similar
found
influenza
virusinfect
mice
suggest
strateg
modul
ifni
signal
could
amelior
patholog
associ
sever
respiratori
viru
infect
collect
studi
suggest
ifni
signal
essenti
cytokin
chemokin
amplif
innat
immun
cell
recruit
promot
excess
immunopatholog
acut
respiratori
viral
infect
fig
importantli
ifni
product
signal
blunt
without
enhanc
viru
propag
follow
acut
respiratori
viral
infect
suggest
pathway
modul
without
compromis
host
antivir
respons
correl
blunt
ifni
signal
lessen
immun
patholog
improv
surviv
multipl
respiratori
viral
infect
highlight
need
mechanist
dissect
ifni
promot
immun
patholog
infect
role
ifni
signal
restrain
chronicpersist
viral
infect
well
document
inhibit
ifni
signal
antibodi
blockad
result
elev
viru
replic
earli
follow
lcmv
infect
treatment
mice
ifni
earli
stage
persist
lcmv
infect
promot
rapid
viru
control
wang
et
al
mechanist
ifni
therapi
increas
expans
virusspecif
cell
prevent
cell
exhaust
howev
whether
due
ifnimedi
immun
stimulatori
effect
lower
antigen
level
systemat
address
addit
studi
report
delet
oligoadenyl
synthetaselik
gene
prior
lcmv
infect
facilit
sustain
ifni
productionsign
promot
cell
expans
reduc
cell
exhaust
promot
rapid
viru
control
lee
park
jeong
kim
ha
similar
persist
lcmv
infect
ifni
administr
exert
protect
effect
slow
siv
replic
diseas
progress
administ
earli
follow
infect
sandler
et
al
shown
efficaci
patient
persist
hiv
infect
asmuth
et
al
azzoni
et
al
moreov
treatment
pegyl
conjunct
antivir
drug
ribavirin
standard
care
treat
patient
chronic
hepat
c
viru
hcv
infect
recent
heim
morenootero
howev
despit
success
hcv
therapi
modest
efficaci
observ
follow
administr
requir
ribavirin
even
combin
slim
major
patient
respond
moreov
patient
fail
control
hcv
follow
ifni
therapi
report
express
higher
ifni
gene
signatur
prior
treatment
sarasinfilipowicz
et
al
similar
trend
observ
follow
ifni
administr
hiv
siv
infect
ifni
administr
modest
effect
given
establish
persist
infect
asmuth
et
al
hubbard
et
al
reason
discrep
observ
human
persist
viral
infect
ifni
therapi
promot
control
hcv
patient
other
establish
hiv
infect
minim
benefit
observ
remain
unknown
one
could
imagin
scenario
persist
infect
hcv
patient
elev
ifni
signatur
persist
addit
pegyl
provid
minim
benefit
patient
lower
ifni
signatur
respond
therapi
whether
treatment
pegyl
earlier
infect
prior
sustain
ifni
signatur
would
benefici
would
interest
discern
similar
profil
appear
exist
persist
siv
infect
earli
administr
ifni
promot
control
viral
load
pathogenesi
later
administr
modest
effect
viral
titer
diseas
outcom
infect
model
gamma
herpesviru
lack
ifni
signal
exacerb
viru
replic
increas
reactiv
latenc
result
enhanc
morbid
mortal
barton
lutzk
rochford
virgin
dutia
allen
dyson
nash
taken
togeth
ifni
therapi
may
benefici
earli
stage
persist
latent
chronic
viral
infect
infect
lower
ifni
signatur
howev
block
ifni
signal
either
alon
conjunct
antivir
immun
checkpoint
therapi
may
prove
effect
viru
persist
elev
ifni
signatur
establish
howev
ultim
outcom
like
depend
persist
viru
studi
genet
suscept
individu
subtyp
time
ifni
speci
produc
requir
investig
moreov
given
undesir
side
effect
ifni
administr
ifn
therapi
much
harm
good
viral
infect
highlight
need
develop
altern
approach
treat
persist
viral
infect
persist
viral
infect
chronic
immun
activ
neg
immun
regul
express
elev
interferon
signatur
lymphoid
tissu
destruct
correl
diseas
progress
elev
ifni
signatur
observ
lcmv
infect
mice
hahm
trifilo
zuniga
oldston
hiv
hcv
infect
human
nonhuman
primat
bosing
et
al
jacquelin
et
al
wieland
et
al
chronic
immun
activ
follow
hiv
infect
report
suppress
hyperactiv
state
propos
potenti
strategi
allevi
hivassoci
patholog
boasso
hardi
anderson
dolan
shearer
dettorr
paiardini
ceccarelli
silvestri
vullo
diseas
follow
experiment
siv
infect
rhesu
macaqu
correl
elev
ifni
product
inflammatori
signatur
jacquelin
et
al
manch
bhardwaj
contrast
siv
infect
sooti
mangabey
african
green
monkey
develop
modest
patholog
despit
equival
viral
load
macaqu
correl
reduc
ifni
inflammatori
gene
signatur
bosing
et
al
similar
correl
respect
reduc
immun
activ
exist
hivinfect
elit
control
although
whether
reduc
immun
activ
follow
viru
control
uncertain
deek
walker
saezcirion
et
al
blockad
signal
chronic
siv
infect
reduc
hyperimmun
activ
microbi
transloc
rhesu
macaqu
lower
ifni
signatur
blood
colon
dyavar
shetti
et
al
moreov
elev
interferon
signatur
observ
hcvinfect
patient
despit
limit
control
viru
replic
develop
liver
patholog
guidotti
chisari
su
et
al
wieland
et
al
fact
hcv
infect
cultur
block
isg
protein
express
activ
rnadepend
protein
kinas
garaigorta
chisari
creat
paradox
ifnidepend
viral
advantag
thu
ifni
signal
pathway
potenti
aid
viral
fit
promot
patholog
persist
viral
infect
studi
highlight
viabil
ifni
signal
system
target
promot
control
persist
viral
infect
literatur
suggest
caus
role
ifni
contribut
pathogenesi
persist
viru
infect
definit
studi
assess
ifni
neutral
affect
outcom
viru
persist
lack
recent
two
laboratori
assess
role
ifni
signal
play
persist
infect
use
lcmv
strain
viru
investig
found
blockad
ifni
signal
use
neutral
antibodi
reduc
immun
system
activ
decreas
express
neg
immun
regulatori
molecul
restor
lymphoid
architectur
mice
persist
infect
lcmv
fig
importantli
blockad
prior
follow
establish
persist
lcmv
infect
promot
faster
viru
clearanc
requir
intact
cell
compart
teijaro
et
al
wilson
et
al
blockad
ifni
signal
significantli
enhanc
cell
differenti
effector
well
increas
fh
cell
differenti
osokin
et
al
studi
demonstr
first
time
direct
causal
link
ifni
signal
immun
activ
neg
immun
regul
express
lymphoid
tissu
disorgan
longterm
viru
persist
recent
report
infect
type
ii
interferon
promot
induct
suppress
capac
immun
regulatori
dc
iregdc
respect
cunningham
et
al
promot
differenti
iregdc
monocyt
ifni
promot
suppress
function
iregdc
genet
delet
prevent
express
product
iregdc
reliev
suppress
capabl
addit
modul
suppress
capac
iregdc
ifni
signal
also
limit
generationexpans
mnov
infect
select
genet
delet
dc
increas
express
cellular
activ
marker
mhcii
suggest
direct
ifni
signal
dc
may
respons
restrain
dc
function
vivo
nice
et
al
gener
elev
number
iregdc
also
observ
hiv
mycobacterium
tuberculosi
infect
well
cancer
suggest
iregdc
gener
common
immunosuppress
environ
ifnidriven
immunesuppress
state
persist
lcmv
infect
also
inhibit
macrophag
function
recent
studi
found
mice
infect
persist
docil
strain
lcmv
impair
humor
immun
respons
superinfect
vsv
infect
honk
et
al
absenc
viru
replic
macrophag
due
antivir
cellmedi
kill
macrophag
instead
result
sustain
ifni
respons
elev
ifni
antivir
gene
program
turn
reduct
vsv
replic
antigen
product
macrophag
reduc
antigen
product
cell
essenti
antivir
antibodi
gener
exist
multipl
ifni
subspeci
speci
mice
human
addit
suggest
either
ifni
system
requir
redund
effect
individu
ifni
speci
evolv
execut
specif
function
certainli
differ
speci
display
vari
degre
affin
receptor
complex
ng
mendoza
garcia
oldston
thoma
et
al
display
highest
bind
affin
lcmv
persist
influenc
signal
treatment
mice
infect
lcmv
neutral
antibodi
display
acceler
viru
clearanc
compar
polyclon
antibodi
minim
effect
viru
control
ng
et
al
neutral
exacerb
earli
viru
replic
improv
lymphoid
architectur
enhanc
virusspecif
cell
respons
howev
neutral
clearli
promot
faster
viru
clearanc
compar
neutral
polyclon
antibodi
contribut
speci
neutral
polyclon
antibodi
use
investig
nevertheless
neutral
may
promot
adapt
immun
control
viru
without
significantli
affect
viru
replic
thu
may
repres
safer
approach
promot
control
persist
viru
infect
vivo
dichotomi
highlight
upon
infect
new
zealand
black
nzb
mice
lcmv
infect
nzb
mice
result
earli
lethal
found
due
celldepend
thrombocytopenia
pulmonari
endotheli
cell
loss
baccala
et
al
interestingli
despit
upregul
express
product
cell
function
remain
intact
moreov
enhanc
patholog
correl
elev
ifni
protein
level
gene
signatur
howev
unlik
infect
mice
patholog
requir
signal
independ
recent
report
signal
requir
bind
independ
delet
amelior
lpsinduc
sepsi
induct
mice
unaffect
de
weerd
et
al
thu
would
interest
test
nzb
mice
respond
infect
studi
demonstr
speci
differenti
modul
immun
respons
variou
viral
infect
highlight
import
futur
investig
differ
ifni
subtyp
modul
viral
control
diseas
pathogenesi
sever
import
question
still
remain
provid
excit
avenu
investig
role
ifni
signal
viral
infect
futur
although
ifni
signal
trigger
variou
downstream
effector
pathway
signal
via
select
ifni
speci
dictat
specif
outcom
follow
viral
infect
remain
incomplet
understood
specif
great
need
understand
role
individu
subset
play
restrain
viral
replic
promot
immun
inflammatorysuppress
program
vivo
ifni
signal
specif
cellular
subset
vivo
regul
immun
patholog
immunesuppress
respons
interest
dissect
mous
strain
gener
recent
instrument
futur
studi
investig
question
illumin
cell
type
requir
ifni
signal
vivo
pave
way
gener
detail
understand
cellular
molecular
mechan
ifni
signal
act
promot
immun
patholog
suppress
acut
persist
viral
infect
capac
ifni
signal
promot
immun
patholog
acut
respiratori
viral
infect
appear
anim
model
influenza
sarscov
infect
necess
ifni
signal
restrain
viral
spread
acut
viral
infect
suggest
target
ifni
signal
pathway
may
ill
advis
howev
one
wonder
whether
target
specif
ifni
speci
suppress
detriment
inflamm
achiev
without
compromis
viru
clearanc
acut
respiratori
viral
infect
moreov
product
respiratori
viral
infect
may
suffici
control
viral
load
ifni
signal
inhibit
recent
result
mous
model
suggest
may
possibl
howev
studi
need
moreov
whether
effect
observ
mice
translat
human
respiratori
viral
infect
unknown
investig
caution
context
immunesuppress
program
elicit
ifni
signal
persist
viru
infect
recent
demonstr
blockad
enhanc
viru
control
induc
improv
lymphoid
architectur
enhanc
virusspecif
cell
respons
suggest
target
select
ifni
speci
redirect
immun
respons
suffici
promot
immunemedi
viru
control
importantli
relief
immunesuppress
environ
case
accompani
elev
viral
load
follow
treatment
antibodi
suggest
select
modul
specif
ifni
speci
allow
preserv
antivir
function
mechan
differ
ifni
speci
interact
receptor
induc
differenti
downstream
signal
suggest
pathway
could
manipul
pharmacolog
interest
postul
whether
small
molecul
biolog
could
develop
block
bindingsign
specif
ifni
speci
ie
specif
exampl
could
signal
select
inhibit
without
alter
speci
engag
receptor
complex
ongo
viral
infect
use
small
molecul
antibodi
therapeut
could
small
molecul
design
revers
aspect
immunesuppress
environ
promot
viru
control
without
compromis
viru
replic
contrari
could
select
ifni
agonist
develop
increas
ifni
signal
product
way
lower
viral
load
bring
persistentchron
viral
infect
control
similar
question
could
posit
acut
viral
infect
ifni
signal
promot
aberr
inflamm
immun
patholog
moreov
would
interest
investig
whether
select
biolog
pharmacolog
modul
ifni
signal
may
translat
treat
autoimmun
diseas
state
associ
elev
sustain
ifni
signal
howev
therapi
enhanc
block
ifni
signal
need
approach
care
given
delic
balanc
act
requir
control
viru
replic
safe
modul
immun
respons
